Market Cap 13.04B
Revenue (ttm) 22.21B
Net Income (ttm) 1.11B
EPS (ttm) N/A
PE Ratio 9.06
Forward PE 10.84
Profit Margin 4.98%
Debt to Equity Ratio 0.53
Volume 950,500
Avg Vol 742,124
Day's Range N/A - N/A
Shares Out 537.13M
Stochastic %K 28%
Beta 0.77
Analysts Hold
Price Target $23.98

Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 49 6172 609 0
Address:
Else-Kröner-Strasse 1, Bad Homburg, Germany
Yi_YandH
Yi_YandH Aug. 6 at 3:15 PM
$IOVA $ICU Medtronic supplies $FMS with SCD components for the device’s assembly. Don’t be surprised if they aren’t part of SeaStar’s international sales, training and distribution conglomerate soon to hatch. DYOR. NFA. https://www.medicaldevice-network.com/news/medtronic-ablation-system-lands-ventricular-arrhythmia-indication-expansion-in-europe/
0 · Reply
Gencooliveoil
Gencooliveoil Aug. 6 at 12:02 PM
0 · Reply
Noname2022
Noname2022 Aug. 5 at 11:53 PM
$CRMD $FMS FMC Q2 earrings call “we are beginning to see the impact of our catheter-related bloodstream infection prevention efforts. We saw a 23% reduction in bloodstream infections over the past year, which supports lower infection-related hospitalizations and also translates into lower patient mortality risk.” https://freseniusmedicalcare.com/content/dam/fresenius-medical-care/global/en/03_investors/pdf/03_publications/2026/q2/Q2_2026_Earnings-call-transcript_Nasdaq.pdf
1 · Reply
REZZAYO
REZZAYO Aug. 5 at 7:04 PM
$CRMD $FMS $DVA Q2 Earnings Season Started to show the first signs of Defencath impact between the two LDOs Davita missed Treatment worsen versus it’s own Plan/ Internal Forecasts While Fresenius Reported favourable improvement on missed Treatment and mortality The Trend will likely expand exponentially
0 · Reply
Noname2022
Noname2022 Aug. 5 at 4:01 PM
2 · Reply
Estimize
Estimize Aug. 5 at 10:01 AM
Wall St is expecting 0.62 EPS for $FMS Q3 [Reporting 11/03 BMO] http://www.estimize.com/intro/fms?chart=historical&metric_name=eps&utm_cont
0 · Reply
Noname2022
Noname2022 Aug. 4 at 11:57 AM
$CRMD $FMS “As already indicated, we are beginning to see the impact of our catheter-related- bloodstream infection prevention efforts. We saw a 23% reduction in bloodstream infections over the past year, which supports lower infection- related hospitalizations and also translates into lower patient mortality risk” https://stockanalysis.com/quote/etr/FME/transcripts/552777-q2-2026/
0 · Reply
EarningsInsider
EarningsInsider Aug. 4 at 9:31 AM
https://www.marketbeat.com/earnings/reports/2026-8-3-fresenius-medical-care-ag-co-kgaa-stock/ $FMS Fresenius Medical Care AG & Co. KGaA Ea
0 · Reply
Noname2022
Noname2022 Aug. 4 at 2:57 AM
$CRMD $FMS Just posting for awarness - New CEO of care delivery for Fresenius who started 8.1.26. https://freseniusmedicalcare.com/en/media/newsroom/fresenius-medical-care-appoints-cassie-mclean-as-new-management-board-member-for-care-delivery/?utm_source=linkedin&utm_medium=organic_social&utm_campaign=03_august2026_caredelivery_announcement&utm_content=corporate
0 · Reply
Noname2022
Noname2022 Aug. 3 at 9:09 PM
$CRMD $DVA $FMS $AKBA https://freseniusmedicalcare.com/content/dam/fresenius-medical-care/global/en/03_investors/pdf/03_publications/2026/q2/FME_Q2_2026_Analyst_Presentation.pdf
1 · Reply
Latest News on FMS
Fresenius Medical Care AG Q2 Sales Increase

2026-08-05T05:36:00.000Z - 5 days ago

Fresenius Medical Care AG Q2 Sales Increase


Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights

Tue, 04 Aug 2026 06:04:04 -0400 - 6 days ago

Fresenius Medical Care AG & Co. KGaA Q2 Earnings Call Highlights


Fresenius Medical Care AG Earnings Call Transcript: Q2 2026

Aug 4, 2026, 4:00 AM EDT - 6 days ago

Fresenius Medical Care AG Earnings Call Transcript: Q2 2026


Fresenius Medical Care AG Earnings release: Q2 2026

Aug 4, 2026, 4:00 AM EDT - 6 days ago

Fresenius Medical Care AG Earnings release: Q2 2026


Fresenius Medical Care AG Slides: Q2 2026

Aug 4, 2026, 4:00 AM EDT - 6 days ago

Fresenius Medical Care AG Slides: Q2 2026


Fresenius Medical Care AG Quarterly report: Q2 2026

Aug 4, 2026, 4:00 AM EDT - 6 days ago

Fresenius Medical Care AG Quarterly report: Q2 2026


Notable Two Hundred Day Moving Average Cross - FMS

2026-06-25T20:05:11.000Z - 6 weeks ago

Notable Two Hundred Day Moving Average Cross - FMS


Fresenius Medical announces EUR 1B share buyback program

2026-05-26T12:05:49.000Z - 2 months ago

Fresenius Medical announces EUR 1B share buyback program


Fresenius Medical Care AG Transcript: AGM 2026

May 21, 2026, 4:00 AM EDT - 2 months ago

Fresenius Medical Care AG Transcript: AGM 2026


Fresenius Medical reappoints CFO Martin Fischer

2026-05-20T17:05:10.000Z - 2 months ago

Fresenius Medical reappoints CFO Martin Fischer


Fresenius Medical Care AG Slides: Investor presentation

May 7, 2026, 8:00 AM EDT - 3 months ago

Fresenius Medical Care AG Slides: Investor presentation


Relative Strength Alert For Fresenius Medical Care

2026-05-05T20:50:04.000Z - 3 months ago

Relative Strength Alert For Fresenius Medical Care


Fresenius Medical Care AG Earnings Call Transcript: Q1 2026

May 5, 2026, 8:00 AM EDT - 3 months ago

Fresenius Medical Care AG Earnings Call Transcript: Q1 2026


Fresenius Medical Care AG Slides: Q1 2026

May 5, 2026, 8:00 AM EDT - 3 months ago

Fresenius Medical Care AG Slides: Q1 2026


Fresenius Medical Care AG Quarterly report: Q1 2026

May 5, 2026, 8:00 AM EDT - 3 months ago

Fresenius Medical Care AG Quarterly report: Q1 2026


Fresenius Medical sees FY26 revenue EUR19.628B

2026-05-05T11:49:09.000Z - 3 months ago

Fresenius Medical sees FY26 revenue EUR19.628B


Fresenius Medical Care Posts Lower Net Profit on One-Off Costs

Tue, 05 May 2026 03:22:00 -0400 - 3 months ago

Fresenius Medical Care Posts Lower Net Profit on One-Off Costs


Fresenius Medical Care's revenue falls in Q1 as weak dollar takes toll

Tue, 05 May 2026 01:08:57 -0400 - 3 months ago

Fresenius Medical Care's revenue falls in Q1 as weak dollar takes toll


Fresenius Medical Care AG Earnings Call Transcript: Q4 2025

Feb 24, 2026, 8:00 AM EST - 5 months ago

Fresenius Medical Care AG Earnings Call Transcript: Q4 2025


Fresenius Medical Care AG Annual report: Q4 2025

Feb 24, 2026, 8:00 AM EST - 5 months ago

Fresenius Medical Care AG Annual report: Q4 2025


Fresenius Medical Care AG Earnings release: Q4 2025

Feb 24, 2026, 8:00 AM EST - 5 months ago

Fresenius Medical Care AG Earnings release: Q4 2025


Fresenius Medical Care AG Slides: Q4 2025

Feb 24, 2026, 8:00 AM EST - 5 months ago

Fresenius Medical Care AG Slides: Q4 2025


Fresenius Medical Care AG Annual report: Q4 2025

Feb 24, 2026, 8:00 AM EST - 5 months ago

Fresenius Medical Care AG Annual report: Q4 2025


Fresenius Medical Care AG Earnings Call Transcript: Q4 2025

Feb 24, 2026, 4:00 AM EST - 5 months ago

Fresenius Medical Care AG Earnings Call Transcript: Q4 2025


Fresenius Medical Care AG Earnings release: Q4 2025

Feb 24, 2026, 4:00 AM EST - 5 months ago

Fresenius Medical Care AG Earnings release: Q4 2025


Fresenius Medical Care AG Slides: Q4 2025

Feb 24, 2026, 4:00 AM EST - 5 months ago

Fresenius Medical Care AG Slides: Q4 2025


Fresenius Medical Care AG Slides: Investor presentation

Feb 24, 2026, 2:00 AM EST - 5 months ago

Fresenius Medical Care AG Slides: Investor presentation


Fresenius Medical Care's operating profit surges in Q4

Feb 24, 2026, 1:08 AM EST - 5 months ago

Fresenius Medical Care's operating profit surges in Q4


Fresenius Medical Care AG Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:00 AM EST - 9 months ago

Fresenius Medical Care AG Earnings Call Transcript: Q3 2025


Fresenius Medical Care AG Quarterly report: Q3 2025

Nov 4, 2025, 8:00 AM EST - 9 months ago

Fresenius Medical Care AG Quarterly report: Q3 2025


Fresenius Medical Care AG Earnings release: Q3 2025

Nov 4, 2025, 8:00 AM EST - 9 months ago

Fresenius Medical Care AG Earnings release: Q3 2025


Fresenius Medical Care AG Slides: Q3 2025

Nov 4, 2025, 8:00 AM EST - 9 months ago

Fresenius Medical Care AG Slides: Q3 2025


Fresenius Medical Care AG Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care AG Earnings Call Transcript: Q2 2025


Fresenius Medical Care AG Earnings release: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care AG Earnings release: Q2 2025


Fresenius Medical Care AG Quarterly report: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care AG Quarterly report: Q2 2025


Fresenius Medical Care AG Slides: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care AG Slides: Q2 2025


Fresenius Medical Care AG Slides: Investor Presentation

Jun 20, 2025, 2:00 AM EDT - 1 year ago

Fresenius Medical Care AG Slides: Investor Presentation


Fresenius Medical Care AG Transcript: CMD 2025

Jun 17, 2025, 5:00 AM EDT - 1 year ago

Fresenius Medical Care AG Transcript: CMD 2025


Fresenius Medical Care AG Slides: FY 2025

Jun 17, 2025, 5:00 AM EDT - 1 year ago

Fresenius Medical Care AG Slides: FY 2025


Fresenius Medical Care AG Transcript: AGM 2025

May 22, 2025, 4:00 AM EDT - 1 year ago

Fresenius Medical Care AG Transcript: AGM 2025


Fresenius Medical Care AG Earnings Call Transcript: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care AG Earnings Call Transcript: Q1 2025


Fresenius Medical Care AG Earnings release: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care AG Earnings release: Q1 2025


Fresenius Medical Care AG Quarterly report: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care AG Quarterly report: Q1 2025


Fresenius Medical Care AG Slides: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Fresenius Medical Care AG Slides: Q1 2025


Fresenius Medical Care AG Earnings Call Transcript: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Earnings Call Transcript: Q4 2024


Fresenius Medical Care AG Annual report: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Annual report: Q4 2024


Fresenius Medical Care AG Annual report: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Annual report: Q4 2024


Fresenius Medical Care AG Quarterly report: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Quarterly report: Q4 2024


Fresenius Medical Care AG Slides: Q4 2024

Feb 25, 2025, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Slides: Q4 2024


Fresenius Medical Care returns to Dax 40 Index

Dec 20, 2024, 11:23 AM EST - 1 year ago

Fresenius Medical Care returns to Dax 40 Index


Fresenius Medical Care AG Earnings Call Transcript: Q3 2024

Nov 5, 2024, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Earnings Call Transcript: Q3 2024


Fresenius Medical Care AG Earnings release: Q3 2024

Nov 5, 2024, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Earnings release: Q3 2024


Fresenius Medical Care AG Quarterly report: Q3 2024

Nov 5, 2024, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Quarterly report: Q3 2024


Fresenius Medical Care AG Slides: Q3 2024

Nov 5, 2024, 8:00 AM EST - 1 year ago

Fresenius Medical Care AG Slides: Q3 2024


Fresenius Medical Care AG Transcript: Expert Call

Sep 16, 2024, 9:00 AM EDT - 2 years ago

Fresenius Medical Care AG Transcript: Expert Call


Fresenius Medical Care AG Slides: Expert Call

Sep 16, 2024, 9:00 AM EDT - 2 years ago

Fresenius Medical Care AG Slides: Expert Call


Fresenius Medical Care AG Earnings Call Transcript: Q2 2024

Jul 30, 2024, 8:00 AM EDT - 2 years ago

Fresenius Medical Care AG Earnings Call Transcript: Q2 2024


Fresenius Medical Care AG Quarterly report: Q2 2024

Jul 30, 2024, 8:00 AM EDT - 2 years ago

Fresenius Medical Care AG Quarterly report: Q2 2024


Fresenius Medical Care AG Earnings release: Q2 2024

Jul 30, 2024, 8:00 AM EDT - 2 years ago

Fresenius Medical Care AG Earnings release: Q2 2024


Fresenius Medical Care AG Slides: Q2 2024

Jul 30, 2024, 8:00 AM EDT - 2 years ago

Fresenius Medical Care AG Slides: Q2 2024


Yi_YandH
Yi_YandH Aug. 6 at 3:15 PM
$IOVA $ICU Medtronic supplies $FMS with SCD components for the device’s assembly. Don’t be surprised if they aren’t part of SeaStar’s international sales, training and distribution conglomerate soon to hatch. DYOR. NFA. https://www.medicaldevice-network.com/news/medtronic-ablation-system-lands-ventricular-arrhythmia-indication-expansion-in-europe/
0 · Reply
Gencooliveoil
Gencooliveoil Aug. 6 at 12:02 PM
0 · Reply
Noname2022
Noname2022 Aug. 5 at 11:53 PM
$CRMD $FMS FMC Q2 earrings call “we are beginning to see the impact of our catheter-related bloodstream infection prevention efforts. We saw a 23% reduction in bloodstream infections over the past year, which supports lower infection-related hospitalizations and also translates into lower patient mortality risk.” https://freseniusmedicalcare.com/content/dam/fresenius-medical-care/global/en/03_investors/pdf/03_publications/2026/q2/Q2_2026_Earnings-call-transcript_Nasdaq.pdf
1 · Reply
REZZAYO
REZZAYO Aug. 5 at 7:04 PM
$CRMD $FMS $DVA Q2 Earnings Season Started to show the first signs of Defencath impact between the two LDOs Davita missed Treatment worsen versus it’s own Plan/ Internal Forecasts While Fresenius Reported favourable improvement on missed Treatment and mortality The Trend will likely expand exponentially
0 · Reply
Noname2022
Noname2022 Aug. 5 at 4:01 PM
2 · Reply
Estimize
Estimize Aug. 5 at 10:01 AM
Wall St is expecting 0.62 EPS for $FMS Q3 [Reporting 11/03 BMO] http://www.estimize.com/intro/fms?chart=historical&metric_name=eps&utm_cont
0 · Reply
Noname2022
Noname2022 Aug. 4 at 11:57 AM
$CRMD $FMS “As already indicated, we are beginning to see the impact of our catheter-related- bloodstream infection prevention efforts. We saw a 23% reduction in bloodstream infections over the past year, which supports lower infection- related hospitalizations and also translates into lower patient mortality risk” https://stockanalysis.com/quote/etr/FME/transcripts/552777-q2-2026/
0 · Reply
EarningsInsider
EarningsInsider Aug. 4 at 9:31 AM
https://www.marketbeat.com/earnings/reports/2026-8-3-fresenius-medical-care-ag-co-kgaa-stock/ $FMS Fresenius Medical Care AG & Co. KGaA Ea
0 · Reply
Noname2022
Noname2022 Aug. 4 at 2:57 AM
$CRMD $FMS Just posting for awarness - New CEO of care delivery for Fresenius who started 8.1.26. https://freseniusmedicalcare.com/en/media/newsroom/fresenius-medical-care-appoints-cassie-mclean-as-new-management-board-member-for-care-delivery/?utm_source=linkedin&utm_medium=organic_social&utm_campaign=03_august2026_caredelivery_announcement&utm_content=corporate
0 · Reply
Noname2022
Noname2022 Aug. 3 at 9:09 PM
$CRMD $DVA $FMS $AKBA https://freseniusmedicalcare.com/content/dam/fresenius-medical-care/global/en/03_investors/pdf/03_publications/2026/q2/FME_Q2_2026_Analyst_Presentation.pdf
1 · Reply
Noname2022
Noname2022 Aug. 3 at 8:28 PM
0 · Reply
Noname2022
Noname2022 Aug. 3 at 6:31 PM
$CRMD $FMS Fresenius Q2 math: Implied incremental TDAPA benefit: €42.7M ≈ $49.7M at $1.163/€ Q2 reimbursement: $4.741/unit × 30 units/vial = $142.23/vial 2 vials/session × 3 sessions/week × 13 weeks = 78 vials/patient 78 × $142.23 = $11,094 reimbursement/patient $49.7M ÷ $11,094 = ~4,480 patients minimum
1 · Reply
Noname2022
Noname2022 Aug. 3 at 6:09 PM
$CRMD $FMS Fresenius Q2 financials imply approximately €42.7M of incremental TDAPA benefit above the phosphate-binder contribution already included in Q2 2025. With phosphate binders likely flat to slightly down YoY, that points to roughly €45M from DefenCath in Q2—right in line with expectations. https://freseniusmedicalcare.com/en/media/newsroom/q2-2026/?utm_source=linkedin&utm_medium=organic_social&utm_campaign=03_august2026_q2_financieal_earnings&utm_content=helen https://freseniusmedicalcare.com/content/dam/fresenius-medical-care/global/en/03_investors/pdf/03_publications/2026/q2/FME_Q2_2026_Financial_Tables.pdf
0 · Reply
Noname2022
Noname2022 Aug. 2 at 1:06 PM
$CRMD $ICUI $DVA $FMS Clearguard HD: guessing DVA contract & best guess at access trends based on their marketing data (Fresenius uses both Clearguard HD & Defencath!) On the Q2 2024 call, ICU Medical said it had: “recently signed a multi-year committed agreement with a leading U.S. operator of dialysis clinics” Management said the agreement would expand its evidence base and help attract other dialysis operators. https://stockanalysis.com/stocks/icui/transcripts/192237-q2-2024/
0 · Reply
Yi_YandH
Yi_YandH Aug. 1 at 7:17 PM
$ICU Vantive’s Cadillac dialysis machine. The Quelimmune SCD-PED will be connected to it(or $FMS ‘s Lincoln, a similar machine) for AKI/Sepsis treatment in 40-50 Children’s hospitals in 4-6 months. The SCD-Adult, will see its connection to the pictured dialysis machine(or a Fresenius built machine)in 50-250 Major US hospitals for the treatment of AKI, Sepsis and ARDS in 6-12 months. Book it. Add. Invest. DYOR. NFA.
0 · Reply
Gencooliveoil
Gencooliveoil Jul. 31 at 1:24 PM
0 · Reply
SparkyReturns
SparkyReturns Jul. 31 at 2:41 AM
$ICU I wonder how many hospitals are familiar with the Seastar SCD device and some affiliated doctors even trained with it, but are holding out until the SAVE registry goes away soon? For example, they are using the adult SCD at the Ronald Reagan Hospital in LA at UCLA, but the 18 bed pediatric wing is not in the SCD-PED study. However, if the SAVE registry requirements are dropped, will Ron Reagan UCLA Pediatric order 5 or 10 treatments so they have them on hand? If the FDA says it works, would it not be medical negligence not to use the new standard of care on a pediatric patient with AKI/Sepsis? I know the answer to that, and I wouldn't want to be that hospital if they didn't order the SCD-PED like stat. I predict there are 5-10 pediatric hospitals in this situation where if the SAVE Registry is dropped, we could have a flood of 25-100 orders overnight at $18,000 per treatment, or an extra $500K-$2M before we know it. GL! $FMS $DVA $BAX
4 · Reply
Yi_YandH
Yi_YandH Jul. 30 at 8:26 PM
$ICU The Right of first refusal to produce of the SCD-Adult once the Neutralize-AKI phase III trial concludes and FDA-PMA is granted belongs to $FMS Fresenius Headquarters: Bad Homburg, Germany Estimated CAGR: 7.4% Past Year Revenue: Approximately USD 24.5 Billion Geographic Presence: More than 100 countries Key Highlights Fresenius remains one of the global leaders in renal care technologies, offering comprehensive CRRT systems, dialysis equipment, consumables, and clinical support services. The company's strong research capabilities, broad product portfolio, and extensive hospital partnerships have established a significant global market presence.
1 · Reply
Noname2022
Noname2022 Jul. 30 at 9:10 AM
$CRMD $FMS After Rezzayo, the most important updates will be Medicare Advantage contracting updates for Defencath imho https://renalinterventions.net/cormedix-announces-interim-results-of-study-of-defencath-in-haemodialysis-patients-with-venous-catheters/
0 · Reply
Yamauchii
Yamauchii Jul. 30 at 8:27 AM
$CRMD $FMS Guys be careful who you are following and influence your investment decisions. Noname is one of the most dumb cherry picker I ever found in any online board. It is even a BAD ai user. I never thought it was possible to use bad AI, but I had to review my thoughts. Someone recently post here the internal memo of FMC leaving the boat for Defencath. Instead of being grateful to receive this insight, some of you are PERMABULLING their line of thought trying to find anywhere any potential confirmation that the info posted was fake. Going back to the root sense of my message. Where the hell the screenshot posted is related to Defencath? It's boned into this cherrypicker's attitude to manipulate adn exploit content like this. Be careful guys. You are following a bad person with very wrong attitude.
2 · Reply
Noname2022
Noname2022 Jul. 29 at 3:10 PM
$CRMD $FMS “innovation means not only introducing new therapies, but also rigorously measuring their impact.” FMC CMO
2 · Reply
Noname2022
Noname2022 Jul. 28 at 4:41 PM
$CRMD $DVA $FMS Study showing safety of using Taurolidine lock solution with a Clearguard HD caps… https://www.sciencedirect.com/science/article/pii/S2468024926010144
0 · Reply